Peptide Profile

Glutathione

Cellular Redox Tripeptide

Overview

Composition

Naturally occurring tripeptide antioxidant composed of three amino acids: glutamine (glutamic acid), cysteine, and glycine; synthesized in nearly every cell with highest concentrations in the liver

Mechanism of Action

Neutralizes free radicals, supports detoxification by conjugating reactive compounds for excretion, regenerates other antioxidants such as vitamins C and E, supports immune-cell function, and maintains cellular redox balance

Primary Effects

Central endogenous antioxidant involved in oxidative-stress control, immune-cell activity, liver detoxification pathways, and cellular protection; levels can vary with age, illness, stress, diet, and exposure burden

Discovery & Background

First identified in 1888 by French biologist J. de Rey-Pailhade, who observed a substance in yeast that reacted with sulfur (initially called "philothion")

In the early 1920s, British biochemist Frederick Gowland Hopkins characterized it further as a dipeptide-like compound containing glutamate and cysteine, coining the term "glutathione"; the full tripeptide structure (γ-L-glutamyl-L-cysteinyl-glycine) was confirmed in 1935 by Charles Harington; research surged in the late 1960s–1970s, highlighting its role in cellular protection, detoxification, and redox regulation

Not FDA-approved as a broad therapeutic antioxidant; evidence and regulatory status vary by indication and product category.

Research Overview

Extensively studied in animal models (e.g., mice, rats) for its protective effects against oxidative stress, neurodegeneration, liver toxicity, inflammation, and immune modulation

01
Central to glutathione peroxidase, glutathione reductase, and detoxification pathways
02
Chemotherapy side-effect mitigation, liver disease, cystic fibrosis, HIV, and skin health
03
Detoxification, neuroprotection, and broad antioxidant-support claims vary in strength by indication and formulation
04
Large-scale randomized controlled trials are limited, with mixed results for some indications
05
Bioavailability differs substantially between glutathione itself and precursor strategies
06
Human outcome data are stronger for selected clinical contexts than for broad wellness claims

Remains a research compound without broad FDA approval for therapeutic use; widely used in wellness contexts

Safety Considerations

Monitoring

Energy levels
Skin appearance and tone
Detoxification markers
Immune function
Overall vitality

Side Effects

Common

Generally well-tolerated
Bloating or cramping has been reported
Headaches
Nausea or transient gastrointestinal discomfort (possibly from rapid toxin mobilization)

Respiratory

Those with asthma should avoid inhaled forms

Contraindications

Copper/metal sensitivities warrant caution
Limited major regulatory approval for medical treatment
Human data are strongest in selected clinical contexts rather than generalized wellness claims
Asthma and allergy history should be reviewed when respiratory exposure is relevant

Educational Notice

Glutathione is central to human redox biology, but supplemental or compounded glutathione should not be treated as a broadly approved medical treatment. Evidence varies by indication and formulation, and clinical decisions require qualified medical oversight.

References